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In the bicentenary year ofthe Royal Victoria Hospital
this review of the ulcer story will have an
unashamedly Ulster bias. Although peptic ulceration
was demonstrated pathologically in the 18th century
the condition was rarely recognised clinically before
the middle of the next century. Gastric ulceration was
the commoner form at that time but by the beginning
ofthe 20th century, duodenal ulceration had overtaken
it. The incidence gradually increased until the middle
of this century and was then followed by a gradual
decline. It is reckoned that even now 5-10% of the
population will suffer the disease at some time in their
lives and 4000-5000 die annually from peptic ulcers in
the British Isles as a result.
Prior to the advent of surgery the limited therapies
available included bland diets, bedrest and antacids,
along with many other less helpful "remedies".
Although the first gastrectomy by Billroth in 1881 and
the first gastroenterostomy by Wolfer the same year,
were for cancer of the stomach, these operations
pioneered the way for peptic ulcer surgery. Rydygier
in November 1881 did the first gastrectomy for a
benign ulcer with pyloric stenosis and subsequently
published the report under the title "The first resection
for stomach ulcer". An editor's footnote said "and I
hope the last". The next few years saw the
establishment of the three main operations for benign
ulcers, namely gastrectomy, gastroenterostomy and
pyloroplasty, all being done initially for the
complications of ulceration. Vagotomy was a much
later introduction. In the Belfast Royal Hospital in
Frederick Street the first gastrectomy for pyloric
obstruction was done by Professor Thomas Sinclair in
18861. In the same hospital in 1897 Sir John Campbell
and Colonel A B Mitchell both closed perforated
duodenal ulcers. At a Belfast meeting of the British
Medical Association in 1909 Colonel A B Mitchell
read a paper from the Royal Victoria Hospital on
twenty eight consecutive operations for duodenal
perforations with three deaths, a remarkable
achievement at that time by a remarkable surgeont2.
The rationale for operations done at this time was
mechanical and physical rather than a knowledge of
aetiology orphysiology. In the case ofpyloric stenosis
a simple gastrojejunostomy was often favoured over
gastrectomy because of its simplicity and lower
mortality. However about athird ofthe patients treated
in this way developed stomal ulceration and as a
consequence gastrectomy again became favoured over
the ulcerogenic operation of simple gastrojejunos-
tomy.
Swartz in 1910 coined the phrase "no acid no ulcer"
but produced no experimental data to back up his
dictum3. It was Dr James Adams, a native of
Glarryford, Co Antrim, a GP practising on the
Ravenhill Road in Belfast, who was the first to
document evidence of the association between
hyperacidity and duodenal ulceration4. His MD thesis
of 1911 outlined acid studies over a six year period in
20 patients with duodenal ulcer. Fourteen had
hyperacidity, 4 had normal acid and 2 had hypoacidity.
He concluded that hyperacidity of the stomach might
predispose to the formation of an ulcer. About the
same time the Russian physiologist, Pavlov, reported
his famous experiments demonstrating the role of the
vagus nerves in gastric secretion in dogs. Latarjet, a
French surgeon, described the detailed anatomy ofthe
vagus nerves in man and in 1922 published a series of
22 patients treated by vagotomy for relief of
abdominal pain5. However, the operations were done
for a "mixed bag" ofconditions and thus vagotomy in
the management of peptic ulceration did not acquire
respectability until the work of Dragstedt in Chicago
in the early 40's6. Dragstedt's first vagotomy in
January 1943 was on a 35 year old man with severe
duodenal ulcer disease and repeated bleeding,
requiring transfusion. The patient was offered
gastrectomy but refused since his father and brother
had had unfortunate experiences with that operation.
Dragstedt then told the patient about his experimental
work on dogs and a few days later the young man had
a trans-thoracic vagotomy with excellent pain relief.
Initially Dragstedt performed transthoracic truncal
vagotomy without drainage but had to re-operate on 3
of his first 15 patients because of gastric emptying
problems. Because of the "post-gastrectomy
syndrome", namely problems of dumping, diarrhoea
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and bile vomiting together with nutritional
disturbances following gastric resection for duodenal
ulceration, surgeons were happy to try the new
procedure of vagotomy and gastrojejunostomy or
vagotomy and pyloroplasty. However, with longer
follow-up recurrent ulceration occurred in 5-15% of
patients following vagotomy and drainage compared
to only 2- 5% following gastrectomy.
Professor John Goligher, an Ulsterman working in
Leeds, reported the results ofa 5-8 year survey of565
patients treated for duodenal ulcer, comparing sub-
total gastrectomy, truncal vagotomy and antrectomy,
truncal vagotomy and pyloroplasty and truncal
vagotomy and gastrojejunostomy7. Although the trial
was not randomised or followed up blindly, vagotomy
and antrectomy produced the best results on Visick
grading. This "belt and braces" operation, taking care
of both the neural and hormonal stimulation of acid,
remained popular in the USA because of a low
recurrent ulceration rate of less than 2% but it carried
a higher mortality than vagotomy and also gave
similar post-operative problems as gastrectomy.
Modifications of the vagotomy operation were
introduced in the 60's. In 1957 Griffith and Harkins
published their experimental data on selective
vagotomy in dogs8. In this operation the hepatic
branches to the liver and gallbladder and the coeliac
branches to the gut are preserved. Initially it did not
catch on but some claimed that it gave a more
complete vagotomy because of the meticulous
dissection required and that it also produced less
diarrhoea than truncal vagotomy. In a randomised
controlled double blind trial during 1966 and 1967,
comparing truncal vagotomy and pyloroplasty with
selective vagotomy and pyloroplasty in elective
duodenal ulcer surgery the late Mr Terence Kennedy
was able to confirm significantly less diarrhoea and
also less recurrent ulceration (though not significant
in) the latter operation9. However, this operation like
truncal vagotomy required a drainage procedure and
there were therefore still problems with dumping and
bile vomiting because of the "incontinent" stomach.
We then set out to compare the two drainage
procedures available and in 1968 embarked on a
further controlled trial comparing selective vagotomy
and pyloroplasty with selective vagotomy and
gastrojejunostomy10. Although there was no
significant difference between the results in the two
groups, there were more satisfied patients in the
gastrojejunostomy group and less recurrent ulcers. In
addition if dumping, diarrhoea or bile vomiting
become a problem following a gastrojejunostomy it
can be closed without difisculty, whereas pyloric
reconstruction is a difficult and often unsuccessful
procedure. It has been said that "if gastrojejunostomy
is a disease then pyloroplasty is an incurable disease".
Thus at this stage of our investigations we favoured
selective vagotomy and gastrojejunostomy as the
operation of choice. In 1969 Andrup of Copenhagan
andJohnston ofLeeds independently described highly
selective vagotomy (also known as proximal gastric
vagotomy) which left sufficient vagal innervation to
the antral pump to allow gastric emptying without the
necessity for a drainage procedurell12. From 1970-
1972 we did a further prospective randomised trial in
the Royal Victoria Hospital, comparing selective
vagotomy and gastrojejunostomy with the new
operation, proximal gastric vagotomy. We found that
dumping and diarrhoea were virtually eliminated by
the proximal gastric vagotomy but that there was a
higher risk of recurrent ulceration'3. In 1990 we
reported the results of 600 consecutive elective
proximal gastric vagotomies for intractable duodenal
ulceration with amortality of0.2%; onepatientdiedin
the post-operative period fromcerebralhaemorrhage'4.
During the 21 year period under review the overall
recurrent ulceration rate was 11%, the majority
controllable by medication. Ninety-two percent ofthe
patients were Visick grade I or II, that is satisfied
patients, which compares well with the "normal"
population at large where the figure is 93%. With a
view to picking out patients who were more liable to
recurrent ulceration following proximal gastric
vagotomy, Mr John Hood looked at the pre-operative
acid studies in over 260 patients who had had
vagotomy'5. He found that there was a highly
significant difference in the basal acid output in
recurrence negative and recurrence positive patients.
Wethereforedecidedto embarkon afurthercontrolled
trial on hypersecretors with basal acids above 10
mmol/l, comparing the results of proximal gastric
vagotomy with truncal vagotomy and antrectomy in
the special group. However, by this time the incidence
of duodenal ulceration was on the decline and the
numbers ofhypersecretors were too small to finish the
trial. In addition a further revolution overtook surgical
management, namely the development of effective
medical therapy.
The discovery of H2 receptor antagonists by Black in
1972 and the subsequent availability of cimetidine in
1976 followed by several similar drugs within a few
years, made medical therapy attractive16. However, it
soon became clear that even on maintenance therapy
with these drugs, 20-25% ofthe patients could expect
endoscopic evidence of recurrent ulceration within a
year. The development ofmore powerful proton pump
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inhibitors such as omeprazole andits successors added
to the phannacological armamentarium. Perhaps the
biggest break through came in 1984 when Marshall
demonstrated the ulcerogenic properties of a spiral
flagellatedbacteria, campylobacterpylori, laterknown
as helicobacter pylori'7. Ninety per cent of duodenal
ulcer patients and 70% of gastric ulcer patients were
shown tobe infected. Modem eradication therapy with
a triple drug regime such as Omeprazole 20 mgs bid,
Clarithromycin 250 mgs bid and Metronidazole 400
mgs bid for aperiod ofone week shouldproduce ulcer
healing in 90% with only a 1% per annum chance of
recurrence. However, there are still problems with
patient non compliance, development of drug
resistance and the onset of ulcer complications
especially in the elderly on NSAID therapy in a few
patients. Modem techniques allow bleeding to be
controlled in most instances by endoscopic injection
therapy, pyloric stenosis by balloon dilatation and
perforation by laparoscopic repair. However, some
patients will come to open surgery and younger
surgeons now have relatively little experience of the
operations required. In the past 10 years, prior to
retirement, I performed, on average, only one ulcer
operation per month and in my last year I operated on
only 3 patients with duodenal ulceration and all were
for complications.
Is this the end of the ulcer story? Undoubtedly the
major role played by surgery in the past has
diminished and a whole new chapter is emerging. The
new villian, H pylori, is becoming better
characterised, and the possibility of new non-
antibiotic therapy and a vaccine against H pylori are
only two of the new possible therapies being written
into the script. Many twists can yetbe expected before
this story comes to an end.
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